Latest Industry Insights

In this interview, Dr. Mitzy Rios de Anda sheds light on the potential of human iPSC-derived astrocytes, discussing how these cells are reshaping our understanding of the brain, neurological diseases and therapeutic development.

Could energy-dispersive X-ray fluorescence spectrometers help improve our understanding of environmental health? Discover how innovative XRF techniques are helping to create a cleaner, healthier world.

Dr. Sergio Pérez Rosal explains why, in his opinion, “hope is not lost” and the therapeutic potential of psychedelics for the treatment of psychiatric disorders could still be unlocked. But what happens next must be firmly rooted in science.

Elsevier’s “Insights 2024: Attitudes toward AI” report reveals how researchers feel about AI and what is needed to increase trust in these tools. Here, Mirit Eldor, managing director, life sciences at Elsevier discusses these findings further.

In this article, JoJo Platt and Ruthi Aladjem from Corundum Neuroscience discuss why 2024 is the year for brain-computer interfaces.

Western blotting is a staple technique in many laboratories but can be time consuming and inconsistent. Technology Networks spoke with Harsha Rao to learn more about Stain-Free western blotting and the advantages of total protein normalization.

This article highlights advancements in neurotechnology that were recently presented in three papers at the 2024 VLSI conference.

To learn more about the FDA's pending decision on MDMA-assisted therapy for PTSD, Technology Networks interviewed Dr. Sam Clark, CEO of Terran Biosciences, who leads one of the industry’s largest psychedelic development programs.

At SLAS Europe 2024, Technology Networks had the pleasure of speaking with Tim Dillon, market manager (Nordics) at Mettler-Toledo Rainin, to learn about how more sustainable options can be implemented into scientists’ daily workflows.

Both genetic and epigenetic sample information is required to get the full picture. Six-base genome sequencing enables this without need of multiple techniques, laborious downstream data processing or data loss, and cancer research is benefiting.